{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "SAVARA INC.  DL-,001", "longName": "Savara Inc.", "messageBoardId": "finmb_59211637", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 1.77, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.6895, "fiftyTwoWeekLowChangePercent": 0.6381305, "fiftyTwoWeekRange": "1.0805 - 2.626", "fiftyTwoWeekHighChange": -0.85599995, "fiftyTwoWeekHighChangePercent": -0.32597104, "fiftyTwoWeekLow": 1.0805, "fiftyTwoWeekHigh": 2.626, "earningsTimestamp": 1680206400, "earningsTimestampStart": 1683889140, "earningsTimestampEnd": 1684152000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.22, "epsForward": -0.34, "epsCurrentYear": -0.38, "priceEpsCurrentYear": -4.6578946, "sharesOutstanding": 114065000, "bookValue": 0.945, "fiftyDayAverage": 1.84972, "fiftyDayAverageChange": -0.07972002, "fiftyDayAverageChangePercent": -0.043098427, "twoHundredDayAverage": 1.64709, "twoHundredDayAverageChange": 0.12291002, "twoHundredDayAverageChangePercent": 0.074622534, "marketCap": 214934640, "forwardPE": -5.205882, "priceToBook": 1.8730159, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.8 - Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChangePercent": 1.7241362, "regularMarketPrice": 1.77, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1199084400000, "priceHint": 4, "regularMarketChange": 0.029999971, "regularMarketTime": 1683880220, "regularMarketDayHigh": 1.77, "regularMarketDayRange": "1.77 - 1.77", "regularMarketDayLow": 1.77, "regularMarketVolume": 150, "regularMarketPreviousClose": 1.74, "bid": 1.77, "ask": 1.81, "symbol": "YB4P.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Building III", "address2": "Suite 201 6836 Bee Cave Road", "city": "Austin", "state": "TX", "zip": "78746", "country": "United States", "phone": "512 614 1848", "website": "https://www.savarapharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Austin, Texas.", "fullTimeEmployees": 28, "companyOfficers": [{"maxAge": 1, "name": "Mr. Matthew  Pauls", "age": 51, "title": "Chairman & CEO", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": {"raw": 894537, "fmt": "894.54k", "longFmt": "894,537"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 273515, "fmt": "273.51k", "longFmt": "273,515"}}, {"maxAge": 1, "name": "Mr. David L. Lowrance CPA", "age": 54, "title": "CFO, Chief Admin. Officer & Sec.", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 613750, "fmt": "613.75k", "longFmt": "613,750"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 55827, "fmt": "55.83k", "longFmt": "55,827"}}, {"maxAge": 1, "name": "Dr. Raymond Dennis Pratt FACP, M.D.", "age": 71, "title": "Chief Medical Officer", "yearBorn": 1951, "fiscalYear": 2022, "totalPay": {"raw": 91889, "fmt": "91.89k", "longFmt": "91,889"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Robert  Lutz M.B.A.", "age": 53, "title": "Chief Operating Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kate  McCabe", "title": "Sr. VP & Gen. Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Anne  Erickson", "title": "Sr. VP & Head of Global Bus. Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Brian  Maurer", "title": "Head of Clinical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Charles  LaPree", "title": "Sr. VP of Global Regulatory Affairs & Quality Assurance", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Peter  Clarke Ph.D.", "age": 62, "title": "Exec. VP of Global Technical Operations", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Scott L. Wilhoit", "age": 58, "title": "Exec. VP of Global Commercial", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 3, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 1, "overallRisk": 4, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}